Verastem (VSTM)

[MaineMan5]

I agree this is an exciting time for $vstm. No clue if FDA approval means a buyout but what I am hoping for is approval prior to the Oct 5 PDUFA date, which is possible due to Priority Review status. The company has said they could do $300 million with their eyes closed on Duvelisib. They recently filed for 200,000 shares for inducement grants of stock options for 9 people which could indicate a ramp up in sales. Plus they have continuing trials in Defactinib, which may turn out to be bigger than Duvelisib but it's too early to tell. I would think using $400M in Duvelisib sales plus continued satisfactory trials in Defactinib, you could argue this company would be worth at least $2 billion to a buyer at minimum. With 74 million shares out, that equates to a price of $27. I think that's pretty conservative, but also assumes FDA approval and continued progress on Defactinib. Management has lots of experience in big pharma (Genzyme, Lilly, Shering Plough, Novartis) so they know how to navigate FDA. Good luck.